buy cheap 2014 unisex Alexander McQueen metal toecap boots official site online cheap sale buy 3LpI6BTL

SKU-0271743765
buy cheap 2014 unisex Alexander McQueen metal toecap boots official site online cheap sale buy 3LpI6BTL
Alexander McQueen metal toecap boots
sale classic Paul Andrew Brancusi boots buy cheap best perfect sale online discount finishline cheap 2014 newest 5bnfY
X Close Message Box

It seems you're using a browser version we no longer support. To get the best online experience, please consider upgrading to one of the following newer browsers.

clearance footlocker discount fake Public Desire Sachi Black Patent Court Shoes CBRTZaHK
PAULA Platform Heels footaction online outlet ebay footaction sale online clearance real y8TCTzsDV1
Apple Safari cheap sale choice pay with visa cheap price Saucony Dxn Vintage Trainers In Red And Pink cheap price low shipping fee cheap looking for vvoDpbS1
cheap footlocker pictures official site online Dsquared2 ankle boots XGZYx3a4zz
Chloé Kyle buckled hitop sneakers discount shopping online xgkIoF
Max Mara textured low top sneakers discount largest supplier 1xzMg2tM3
GlobeNewswire
discount get to buy sale high quality Billionaire laceup sneakers outlet amazing price sneakernews cheap online buy cheap countdown package 4suWH
Nike Air Max Axis Mens Sneakers clearance ebay sale view 3f2xvkSXa
Giuseppe Zanotti Design Cedric toe cap loafers discount Manchester Manchester cheap price buy cheap latest collections buy cheap collections free shipping from china CDaviLXd
Français

Topline results from the first of three Phase 3 trials in psoriasis clinical development program

Share
| Source: Dermira, Inc.

BRUSSELS, Belgium and MENLO PARK, Calif., Oct. 03, 2016 (GLOBE NEWSWIRE) -- UCB (Euronext:UCB) and Dermira, Inc. (NASDAQ:) today announced topline results from CIMPASI-2, a Phase 3, multi-center, placebo-controlled clinical trial evaluating the efficacy and safety of CIMZIA® (certolizumab pegol) in adult patients with moderate-to-severe chronic plaque psoriasis. In the CIMPASI-2 trial, CIMZIA demonstrated statistically significant improvements for both co-primary endpoints compared to placebo at both treatment doses. The CIMPASI-2 trial results are from the first of three Phase 3 clinical trials to be reported evaluating CIMZIA in this patient population. 1

The co-primary endpoints evaluated in the trial were the percentage of patients who achieved a 75% or greater disease improvement from baseline as measured by the Psoriasis Area and Severity Index (PASI 75) and the percentage of patients achieving at least a two-point improvement on a five-point Physician’s Global Assessment (PGA) scale to a final score representing clear or almost clear skin, each compared with placebo, at week 16. 1

A total of 227 patients with moderate-to-severe chronic plaque psoriasis were randomized to three dosing arms—400 mg every two weeks (n=87), 400 mg at weeks 0, 2, and 4 followed by 200 mg every two weeks (n=91), or placebo every two weeks (n=49). At week 16, the response rate for patients who achieved a PASI 75 was 82.6% for patients receiving the 400 mg dose every two weeks and 81.4% for patients receiving the 200 mg dose every two weeks, compared to 11.6% for patients receiving placebo. The response rate for patients achieving at least a two-point improvement to a final score of clear or almost clear skin on the PGA scale at week 16 was 71.6% for the 400 mg dose-treated patients and 66.8% for the 200 mg dose-treated patients, compared to 2.0% for the patients receiving placebo. CIMZIA demonstrated statistically significant improvements from baseline to week 16 relative to placebo for both co-primary endpoints at both treatment doses. The adverse event profile appears consistent with the adverse event profiles observed with CIMZIA in other indications. 1

“The clinical results from the CIMPASI-2 trial are very encouraging and reinforce our belief that CIMZIA may provide clinically meaningful benefit for moderate-to-severe plaque psoriasis patients,” said Tom Wiggans, chairman and chief executive officer of Dermira. “We look forward to data from the two additional ongoing Phase 3 clinical trials, which are expected by the end of the first quarter of 2017.”

Limited time offer: Use code 'FLYJULY18' for 3 months of FREE hosting!

Limited time offer:
Sign up

Never share passwords or create multiple logins again

•••

Streamline your collaboration process

You know you’ve done it — you’ve totally built a spreadsheet with all your client passwords in one place. Flywheel does away with all that. Collaborate easily and instantly with your team without the clunkiness of sharing and storing (and losing. And recovering) passwords.

Fifty and Fifty spends more time building client projects and zero time managing servers

Bryan Monzon is the vice president of engineering at Fifty and Fifty, a company that works on digital products (small and large) for social good. Since starting on Flywheel, Fifty and Fifty have sped up their project complete time and eliminated workflow headaches along the way.

DOWNLOAD

Ditch the spreadsheet filled with passwords. Never ask a client for a password again. Collaborators on Flywheel log in with their own usernames and passwords. They can view and manage all their sites in one place.

Add teammates and clients as collaborators, and they’ll get full access to manage the site, update files, and manage the database.

•••

It’s okay to fall in love with your Flywheel dashboard. Look how pretty it is, showing all the sites you own right next to the ones where you’re a collaborator. With just one login, you can manage all your sites, upload files via SFTP, and modify databases.

When the project is over, remove access from people who don’t need it anymore, and voilà! No more access.

footaction for sale Journee Collection Jamie Womens Mary Jane Heels clearance store best seller mh8Dbx

Wyman Projects uses Flywheel to centralize their workflow

Mens Georgia Bulldogs Striped Flip Flop Sandals sale store order cheap online w9HGB

Try it yourself. It's free takes less than 60 seconds. SIGN UP

Reimagined SFTP

You know you’ve done it – a spreadsheet with all your client passwords in one place. Flywheel frees you from the need to share and store passwords.

New Look Wide Fit VelVEt Dark Leopard Print Pointed Court Shoe cheap sale new buy cheap wide range of buy cheap 100% original cheap sale visit new aGSe5Nv
•••
•••

Test out changes in a test enviroment and easily push to production.

Sleep soundly at night knowing that all your important files are backed up nightly.

When you're done developing, easily transfer a site to your client for payment.

Powerful Tools

Managed Hosting

We'd love hearing from you. Give us a call and we can chat about your needs.

See for yourself how Flywheel can make your life easier.

© GG.COM 2018 | sale best place outlet get authentic Womens Sperry Nellie Kate Rain Boots largest supplier cheap price discount official site D18sX
18+
v5.31.1 | Served in 0.21s by frontend-03